Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Differential effects on ARF stability by normal versus oncogenic levels of c-Myc expression.

Chen D, Kon N, Zhong J, Zhang P, Yu L, Gu W.

Mol Cell. 2013 Jul 11;51(1):46-56. doi: 10.1016/j.molcel.2013.05.006. Epub 2013 Jun 6.

2.

The ARF tumor suppressor: keeping Myc on a leash.

Gregory MA, Qi Y, Hann SR.

Cell Cycle. 2005 Feb;4(2):249-52. Epub 2005 Feb 21.

PMID:
15655352
3.

Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses.

Chen D, Shan J, Zhu WG, Qin J, Gu W.

Nature. 2010 Mar 25;464(7288):624-7. doi: 10.1038/nature08820. Epub 2010 Mar 7.

4.

p19ARF directly and differentially controls the functions of c-Myc independently of p53.

Qi Y, Gregory MA, Li Z, Brousal JP, West K, Hann SR.

Nature. 2004 Oct 7;431(7009):712-7. Epub 2004 Sep 8.

PMID:
15361884
5.

Reactivating the ARF-p53 axis in AML cells by targeting ULF.

Chen D, Yoon JB, Gu W.

Cell Cycle. 2010 Aug 1;9(15):2946-51. doi: 10.4161/cc.9.15.12355. Epub 2010 Aug 11.

6.

NMI mediates transcription-independent ARF regulation in response to cellular stresses.

Li Z, Hou J, Sun L, Wen T, Wang L, Zhao X, Xie Q, Zhang SQ.

Mol Biol Cell. 2012 Dec;23(23):4635-46. doi: 10.1091/mbc.E12-04-0304. Epub 2012 Oct 3.

7.

Myc-ARF (alternate reading frame) interaction inhibits the functions of Myc.

Datta A, Nag A, Pan W, Hay N, Gartel AL, Colamonici O, Mori Y, Raychaudhuri P.

J Biol Chem. 2004 Aug 27;279(35):36698-707. Epub 2004 Jun 15.

8.

ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor.

Chen D, Kon N, Li M, Zhang W, Qin J, Gu W.

Cell. 2005 Jul 1;121(7):1071-83.

9.

Characterization of ARF-BP1/HUWE1 interactions with CTCF, MYC, ARF and p53 in MYC-driven B cell neoplasms.

Qi CF, Kim YS, Xiang S, Abdullaev Z, Torrey TA, Janz S, Kovalchuk AL, Sun J, Chen D, Cho WC, Gu W, Morse HC 3rd.

Int J Mol Sci. 2012;13(5):6204-19. doi: 10.3390/ijms13056204. Epub 2012 May 21.

10.

Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.

Eischen CM, Packham G, Nip J, Fee BE, Hiebert SW, Zambetti GP, Cleveland JL.

Oncogene. 2001 Oct 25;20(48):6983-93.

11.

Regulation of Myc function by ARF: checkpoint for Myc-induced oncogenesis.

Sarkar D, Fisher PB.

Cancer Biol Ther. 2006 Jun;5(6):693-5. Epub 2006 Jun 25.

PMID:
16775430
12.

The Myc-nucleophosmin-ARF network: a complex web unveiled.

Li Z, Hann SR.

Cell Cycle. 2009 Sep 1;8(17):2703-7. Epub 2009 Sep 2. Review.

13.

Nucleostemin stabilizes ARF by inhibiting the ubiquitin ligase ULF.

Lo D, Zhang Y, Dai MS, Sun XX, Zeng SX, Lu H.

Oncogene. 2015 Mar 26;34(13):1688-97. doi: 10.1038/onc.2014.103. Epub 2014 Apr 28.

14.

Arf tumor suppressor disrupts the oncogenic positive feedback loop including c-Myc and DDX5.

Tago K, Funakoshi-Tago M, Itoh H, Furukawa Y, Kikuchi J, Kato T, Suzuki K, Yanagisawa K.

Oncogene. 2015 Jan 15;34(3):314-22. doi: 10.1038/onc.2013.561. Epub 2014 Jan 27.

PMID:
24469041
15.

E2F activity is essential for survival of Myc-overexpressing human cancer cells.

Santoni-Rugiu E, Duro D, Farkas T, Mathiasen IS, Jäättelä M, Bartek J, Lukas J.

Oncogene. 2002 Sep 19;21(42):6498-509.

16.

ARF differentially modulates apoptosis induced by E2F1 and Myc.

Russell JL, Powers JT, Rounbehler RJ, Rogers PM, Conti CJ, Johnson DG.

Mol Cell Biol. 2002 Mar;22(5):1360-8.

17.

Controlling ARF stability: new players added to the team.

Tavana O, Chen D, Gu W.

Cell Cycle. 2014;13(4):497-8. doi: 10.4161/cc.27786. Epub 2014 Jan 13. No abstract available.

PMID:
24419106
18.

Egr1 mediates p53-independent c-Myc-induced apoptosis via a noncanonical ARF-dependent transcriptional mechanism.

Boone DN, Qi Y, Li Z, Hann SR.

Proc Natl Acad Sci U S A. 2011 Jan 11;108(2):632-7. doi: 10.1073/pnas.1008848108. Epub 2010 Dec 27.

19.

Gliomagenesis arising from Pten- and Ink4a/Arf-deficient neural progenitor cells is mediated by the p53-Fbxw7/Cdc4 pathway, which controls c-Myc.

Kim HS, Woolard K, Lai C, Bauer PO, Maric D, Song H, Li A, Kotliarova S, Zhang W, Fine HA.

Cancer Res. 2012 Nov 15;72(22):6065-75. doi: 10.1158/0008-5472.CAN-12-2594. Epub 2012 Sep 17.

20.

Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis.

Eischen CM, Roussel MF, Korsmeyer SJ, Cleveland JL.

Mol Cell Biol. 2001 Nov;21(22):7653-62.

Supplemental Content

Support Center